SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-135135
Filing Date
2019-05-02
Accepted
2019-05-02 16:46:32
Documents
3
Effectiveness Date
2019-05-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A d737315ddefa14a.htm DEFA14A 55531
2 GRAPHIC g737315g0423111548543.jpg GRAPHIC 10766
3 GRAPHIC g737315g0423111548684.jpg GRAPHIC 2209
  Complete submission text file 0001193125-19-135135.txt   74042
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 19792625
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences